{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:55:23Z","timestamp":1791204923021,"version":"4.1.0"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"DOI":"10.1245\/s10434-026-20705-1","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:28:30Z","timestamp":1791203310000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ASO Author Reflections: Beyond Eligibility: Is Universal Germline Testing the Answer to Undertesting?"],"prefix":"10.1245","author":[{"given":"K.","family":"Velazquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"Alberty-Oller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"20705_CR1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1200\/JCO.18.01631","volume":"37","author":"PD Beitsch","year":"2019","unstructured":"Beitsch PD, Whitworth PW, Hughes K, et al. Underdiagnosis of hereditary breast cancer: Are genetic testing guidelines a tool or an obstacle? J Clin Oncol. 2019;37:453\u201360. https:\/\/doi.org\/10.1200\/JCO.18.01631.","journal-title":"J Clin Oncol."},{"key":"20705_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1245\/s10434-020-09123-z","volume":"28","author":"JJ Alberty-Oller","year":"2021","unstructured":"Alberty-Oller JJ, Weltz S, Santos A, et al. Adherence to NCCN guidelines for genetic testing in breast cancer patients: Who are we missing? Ann Surg Oncol. 2021;28:281\u20136. https:\/\/doi.org\/10.1245\/s10434-020-09123-z.","journal-title":"Ann Surg Oncol."},{"key":"20705_CR3","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1245\/s10434-019-07549-8","volume":"26","author":"ER Manahan","year":"2019","unstructured":"Manahan ER, Kuerer HM, Sebastian M, et al. Consensus guidelines on genetic testing for hereditary breast cancer from the American Society of Breast Surgeons. Ann Surg Oncol. 2019;26:3025\u201331. https:\/\/doi.org\/10.1245\/s10434-019-07549-8.","journal-title":"Ann Surg Oncol."},{"key":"20705_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2023.107210","volume":"130","author":"VB Sheppard","year":"2023","unstructured":"Sheppard VB, Sutton AL, Hurtado-de-Mendoza A, et al. Addressing disparities in the uptake of genetic counseling and testing in African American women: rationale, design and methods. Contemp Clin Trials. 2023;130:107210. https:\/\/doi.org\/10.1016\/j.cct.2023.107210.","journal-title":"Contemp Clin Trials."},{"key":"20705_CR5","doi-asserted-by":"publisher","unstructured":"Velazquez K, Jeng A, Roudakova K, Alberty-Oller JJ. Universal versus guideline-directed germline testing in breast cancer: incremental diagnostic yield in a predominantly Black population. Ann Surg Oncol. 2026. https:\/\/doi.org\/10.1245\/s10434-026-20637-w.","DOI":"10.1245\/s10434-026-20637-w"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20705-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20705-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20705-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:28:30Z","timestamp":1791203310000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20705-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":5,"alternative-id":["20705"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20705-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"22 September 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Portions of this work were presented as a poster presentation at the\n                      American Society of Breast Surgeons\n                      conference, Seattle, Washington, May 2026. No conflicts of interest or financial grants to disclose.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}